2020
DOI: 10.4196/kjpp.2020.24.3.241
|View full text |Cite
|
Sign up to set email alerts
|

Heat shock protein 90 inhibitor AUY922 attenuates platelet-derived growth factor-BB-induced migration and proliferation of vascular smooth muscle cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…Ox-LDL (80 μg/ml) was treated to primary VSMC for periods of 0, 3, 6, 12, 24 and 48 h and different concentrations of ox-LDL (0, 20, 40, 80, 160 μg/ml) were incubated for 24 h. The experiment was then divided into four groups, including the Control group, ox-LDL ( Li et al, 2014 ) (80 μg/ml, 24 h) group, ox-LDL + Gap 26 ( Wang et al, 2019b ) (Cx43 specific inhibitor, 100 μM pretreatment for 45 min, and then ox-LDL for 24 h,) group, ox-LDL + LY294002 ( Kim et al, 2020 ) (20 μM pretreatment for 30 min and then ox-LDL for 24 h) group, and the Gap 26 group.…”
Section: Methodsmentioning
confidence: 99%
“…Ox-LDL (80 μg/ml) was treated to primary VSMC for periods of 0, 3, 6, 12, 24 and 48 h and different concentrations of ox-LDL (0, 20, 40, 80, 160 μg/ml) were incubated for 24 h. The experiment was then divided into four groups, including the Control group, ox-LDL ( Li et al, 2014 ) (80 μg/ml, 24 h) group, ox-LDL + Gap 26 ( Wang et al, 2019b ) (Cx43 specific inhibitor, 100 μM pretreatment for 45 min, and then ox-LDL for 24 h,) group, ox-LDL + LY294002 ( Kim et al, 2020 ) (20 μM pretreatment for 30 min and then ox-LDL for 24 h) group, and the Gap 26 group.…”
Section: Methodsmentioning
confidence: 99%
“…Western blotting was performed as previously described [ 17 ]. The A569 cells were seeded (1 × 10 6 cells/mL) in a 100-mm dish.…”
Section: Methodsmentioning
confidence: 99%
“… 10 11 12 Of various growth factors involved in the VSMC phenotype switching, the platelet-derived growth factor (PDGF) is an important growth factor that stimulates synthetic phenotype switching of VSMCs, leading to enhanced VSMC migration and proliferation in the development of atherosclerosis. 11 13 14 Clinically, it was reported that restenosis occurs within the first six months in 30–40% of patients who have previously undergone percutaneous balloon angioplasty. 15 Furthermore, the aberrant proliferation of VSMCs has been considered critical in developing in-stent restenosis, transplant vasculopathy, and vein bypass graft failure.…”
Section: Introductionmentioning
confidence: 99%